Stay updated with breaking news from Yonjin Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell sorting solutions. Local investors such as FusionX Ventures, Anzu Partners and Agilent Technologies are among those backing the San Diego biotech.
Exicure and Bluejay Therapeutics have reached a patent licencing agreement for the development of cavrotolimod as a potential hepatitis treatment.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Intressa Vascular is using its proprietary stent braiding technology to develop an innovative multilayer stent for the treatment of aortic dissection, a life-threatening cardiovascular condition affecting worldwide 300,000 patients annually. The company has secured EUR 18 million in financing with the support of ...